Clinical Trials Directory

Trials / Conditions / Infection Viral

Infection Viral

45 registered clinical trials studyying Infection Viral4 currently recruiting.

StatusTrialSponsorPhase
RecruitingMicrobial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
NCT07110636
Karius, Inc.N/A
WithdrawnNosocomial Influenza Surveillance of 2022 - 2027 Seasonal Period
NCT05712759
Hospices Civils de Lyon
CompletedAccess MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
NCT06379061
Beckman Coulter, Inc.
CompletedDevelopment and Validation of (Bio)Sensors for the Identification of Pathogens
NCT06548841
University of Bologna
CompletedXofluza-Wearables Feasibility-Study
NCT06161454
Children's Hospital of PhiladelphiaPhase 4
CompletedRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
NCT06149494
Altesa Biosciences, Inc.Phase 2
RecruitingXanthohumol and Viral Infections (XL)
NCT06286657
University of ViennaN/A
CompletedStudy to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vacc
NCT05875961
SeqirusPhase 1
CompletedStudy to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and
NCT05874713
SeqirusPhase 2
CompletedMedicine-induced Cardiac Hemodialysis on COVID-19
NCT05711810
Yang I. PachankisPhase 4
RecruitingTowards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
NCT06178822
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
CompletedA Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) an
NCT05069623
Nykode Therapeutics ASAPhase 1 / Phase 2
UnknownMicro-hematology Analyzer for Viral/Bacterial Description
NCT05090319
RizLab Health, Inc.
UnknownEfficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
NCT04887233
Chulalongkorn UniversityN/A
CompletedCOVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor P
NCT04924842
Hospices Civils de Lyon
WithdrawnUse of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
NCT04684550
Hospital Universitario San IgnacioPhase 2 / Phase 3
TerminatedPredicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075
Imperial College London
CompletedCOVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
NCT04782427
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
CompletedCOVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor)
NCT04664296
Hospices Civils de Lyon
UnknownExercise Influence on COVID-19
NCT04624048
University of Salamanca
CompletedCOVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMU
NCT04637867
Hospices Civils de LyonN/A
CompletedRNA Sequencing of Individual Versus Wastewater - SARS-CoV2
NCT05041764
Centre Hospitalier Universitaire de Nice
CompletedThe Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
NCT04239521
Momentum Data
UnknownCOVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
NCT04481529
University Hospital, Limoges
CompletedComparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines
NCT04754633
Seyhmus Kavak
CompletedCOVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
NCT04354155
Johns Hopkins All Children's HospitalPhase 2
CompletedCovid-19 and Prevention of Malnutrition After Confinement by Dentists
NCT04386460
Centre Hospitalier Universitaire de Nice
CompletedScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Ca
NCT04367740
University of North Carolina, Chapel Hill
CompletedA Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocom
NCT04380701
BioNTech SEPhase 1 / Phase 2
CompletedPrevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in
NCT04336761
University Hospital, Lille
CompletedPredictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
NCT04341792
University Hospital, Lille
CompletedEarly Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF
NCT04344327
French Cardiology Society
CompletedTARGet Kids! COVID-19 Study of Children and Families
NCT04449978
The Hospital for Sick Children
TerminatedProactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
NCT04322396
Chronic Obstructive Pulmonary Disease Trial Network, DenmarkPhase 2
UnknownCOVID-19 Biological Samples Collection
NCT04332016
University Hospital, Bordeaux
WithdrawnHCQ for Primary Prophylaxis Against COVID19 in Health-care Workers
NCT04336748
Medical University of ViennaPhase 3
CompletedPrognostic Significance of COVID-19 MSCT Chest Findings on Short Term Disease Progression
NCT05235373
Benha University
CompletedPREdiction of DIagnosed Covid-19 infecTion in IUC Patients
NCT04327180
University Hospital, Lille
UnknownEvaluation of Immune Response in COVID-19 Patients
NCT04438629
Azienda Ospedaliera Universitaria Integrata Verona
CompletedCOVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
NCT04290780
Hospices Civils de Lyon
UnknownClinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavi
NCT04315870
Federico II University
UnknownClinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
NCT04319016
Federico II University
RecruitingPost Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malign
NCT03818334
Hospital Israelita Albert EinsteinPhase 2 / Phase 3
CompletedbiomArkers to differeNtiate bacTerial From vIral iNfEctions
NCT03163628
Hospices Civils de LyonN/A
CompletedHigh-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
NCT03598452
Aier School of Ophthalmology, Central South UniversityN/A